Caloric restriction reverses high-fat diet-induced endothelial dysfunction and vascular superoxide production in C57Bl/6 mice

Heart and Vessels

Volumn 25, Issue 3, 2010, Pages 254-262

  Ketonen, Juha ^a   Pilvi, Taru ^b   Mervaala, Eero ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Endothelium; Nitric oxide; Obesity; Oxidative stress; Superoxide

Indexed keywords

ACETYLCHOLINE; APOCYNIN; ARGINASE; ARGININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NORVALINE; OXIPURINOL; SEPIAPTERIN; SUPEROXIDE; TIRON;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALORIC INTAKE; CALORIC RESTRICTION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR RING; VASODILATATION; WESTERN BLOTTING;

ANIMALS; ARGINASE; BIOPTERIN; BODY WEIGHT; CALORIC RESTRICTION; CARDIOVASCULAR DISEASES; DIETARY FATS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; MALE; MICE; MICE, INBRED C57BL; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OBESITY; PHOSPHORYLATION; SUPEROXIDES; TIME FACTORS; VASODILATION; VASODILATOR AGENTS; XANTHINE OXIDASE;

EID: 77956144207     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-009-1182-x     Document Type: Article

References (45)

1. Lindgren CM, McCarthy MI (2008) Mechanisms of disease: genetic insights into the etiology of type 2 diabetes and obesity. Natl Clin Pract Endocrinol Metab 4(3):156-163
2. Avogaro A, de Kreutzenberg SV (2005) Mechanisms of endothelial dysfunction in obesity. Clin Chim Acta 360(1-2):9-26
3. Van Gaal LF, Mertens IL, De Block CE (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444(7121): 875-880
4. Heistad DH (2006) Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 26:689-695
5. Pechánová O, Simko F (2007) The role of nitric oxide in the maintenance of vasoactive balance. Physiol Res 56 suppl 2:S7-S16
6. Stuehr D, Pou S, Rosen GM (2001) Oxygen reduction by nitricoxide synthases. J Biol Chem 276(18):14533-14536
7. Takaya T, Hirata K, Yamashita T, Shinohara M, Sasaki N, Inoue N, Yada T, Goto M, Fukatsu A, Hayashi T, Alp NJ, Channon KM, Yokoyama M, Kawashima S (2007) A specifi c role for eNOSderived reactive oxygen species in atherosclerosis progression. Arterioscler Thromb Vasc Biol 27(7):1632-1637
8. Alp NJ, Mussa S, Khoo J, Cai S, Guzik T, Jefferson A Goh N, Rockett KA, Channon KM (2003) Tetrahydrobiopterindependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. J Clin Invest 112(5):725-735
9. Mitchell BM, Cook LG, Danchuk S, Puschett JB (2007) Uncoupled endothelial nitric oxide synthase and oxidative stress in a rat model of pregnancy-induced hypertension. Am J Hypertens 20(12):1297-1304
10. Parekh PI, Petro AE, Tiller JM, Feinglos MN, Surwit RS (1998) Reversal of diet-induced obesity and diabetes in C57BL/6J mice. Metabolism 47(9):1089-1096
11. Traupe T, D'Uscio LV, Muenter K, Morawietz H, Vetter W, Barton M (2002) Effects of obesity on endothelium-dependent reactivity during acute nitric oxide synthase inhibition: modulatory role of endothelin. Clin Sci (Lond) 103 suppl 48:13S-15S
12. Barton M, Carmona R, Morawietz H, d'Uscio LV, Goettsch W, Hillen H Haudenschild CC, Krieger JE, Münter K, Lattmann T, Lüscher TF, Shaw S (2000) Obesity is associated with tissuespecifi c activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin. Hypertension 35(1 Pt 2):329-336
13. Mundy AL, Haas E, Bhattacharya I, Widmer CC, Kretz M, Hofmann-Lehmann R (2007) Fat intake modifi es vascular responsiveness and receptor expression of vasoconstrictors: implications for diet-induced obesity. Cardiovasc Res 73(2):368-375
14. Traupe T, Lang M, Goettsch W Münter K, Morawietz H, Vetter W (2002) Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression. J Hypertens 20(11):2239-2245
15. Molnar J, Yu S, Mzhavia N, Pau C, Chereshnev I, Dansky HM (2005) Diabetes induces endothelial dysfunction but does not increase neointimal formation in high-fat diet fed C57BL/6J mice. Circ Res 96(11):1178-1184
16. Noronha BT, Li JM, Wheatcroft SB, Shah AM, Kearney MT (2005) Inducible nitric oxide synthase has divergent effects on vascular and metabolic function in obesity. Diabetes 54(4): 1082-1089
17. Ketonen J, Merasto S, Paakkari I, Mervaala EM (2005) High sodium intake increases vascular superoxide formation and promotes atherosclerosis in apolipoprotein E-defi cient mice. Blood Press 14(6):373-382
18. Ketonen J. Mervaala EMA (2008) Effects of dietary sodium on ROS formation and endothelial dysfunction in LDL receptor defi-cient mice on high fat diet. Heart Vessels 23(6):420-429
19. Ahotupa M, Marniemi J, Lehtimäki T, Talvinen K, Raitakari OT, Vasankari T (1998) Baseline diene conjugation in LDL lipids as a direct measure of in vivo LDL oxidation. Clin Biochem 31:245-261
20. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114(12):1752-1761
21. Sonta T, Inoguchi T, Tsubouchi H, Sekiguchi N, Kobayashi K, Matsumoto S, Utsumi H, Nawata H (2004) Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity. Free Radic Biol Med 37(1):115-123
22. Erdei N, Tóth A, Pásztor ET, Papp Z, Edes I, Koller A. Bagi Z (2006) High-fat diet-induced reduction in nitric oxide-dependent arteriolar dilation in rats: role of xanthine oxidase-derived superoxide anion. Am J Physiol Heart Circ Physiol 291(5): H2107-H2115
23. Shinozaki K, Nishio Y, Ayajiki K, Yoshida Y, Masada M, Kashiwagi A, Okamura T (2007) Pitavastatin restores vascular dysfunction in insulin-resistant state by inhibiting NAD(P)H oxidase activity and uncoupled endothelial nitric oxide synthasedependent superoxide production. J Cardiovasc Pharmacol 49(3): 122-130
24. Moien-Afshari F, Ghosh S, Khazaei M, Kieffer TJ, Brownsey RW, Laher I (2008) Exercise restores endothelial function independently of weight loss or hyperglycaemic status in db/db mice. Diabetologia 51(7):1327-1337
25. Keenan KP, Laroque P, Dixit R (1998) Need for dietary control by caloric restriction in rodent toxicology and carcinogenicity studies. J Toxicol Environ Health B Crit Rev 1(2):135-148
26. Ryoo S, Gupta G, Benjo A, Lim HK, Camara A, Sikka G, Lim HK, Sohi J, Santhanam L, Soucy K, Tuday E, Baraban E, Ilies M, Gerstenblith G, Nyhan D, Shoukas A, Christianson DW, Alp NJ, Champion HC, Huso D, Berkowitz DE (2008) Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circ Res 102(8):923-932
27. Kim F, Pham M, Maloney E, Rizzo NO, Morton GJ, Wisse BE, Kirk EA, Chait A, Schwartz MW (2008) Vascular infl ammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol 28(11):1982-1988
28. Dikalov S, Griendling KK, Harrison DG (2007) Measurement of reactive oxygen species in cardiovascular studies. Hypertension 49:717-727
29. Münzel T, Daiber A, Ullrich V, Mülsch A (2005) Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol 25(8):1551-1557
30. Palm F, Onozato ML, Luo Z, Wilcox CS (2007) Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol 293(6):H3227-H3245
31. Durante W, Johnson FK, Johnson RA (2007) Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 34(9):906-911
32. Korda M, Kubant R, Patton S, Malinski T (2008) Leptin-induced endothelial dysfunction in obesity. Am J Physiol Heart Circ Physiol 295(4):H1514-H1521
33. Siasos G, Tousoulis D, Antoniades C, Stefanadi E, Stefanadis C (2007) L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis? Int J Cardiol 116(3): 300-308
34. McNally JS, Davis ME, Giddens DP, Saha A, Hwang J, Dikalov S. Jo H, Harrison DG (2003) Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Heart Circ Physiol 285(6):H2290-H2297
35. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG (2003) Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111(8):1201-1209
36. Aldieri E, Riganti C, Polimeni M, Gazzano E, Lussiana C, Campia I, Ghigo D (2008) Classical inhibitors of NOX NAD(P)H oxidases are not specifi c. Curr Drug Metab 9(8):686-696
37. Das DK, Engelman RM, Clement R, Otani H, Prasad MR, Rao PS (1987) Role of xanthine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage. Biochem Biophys Res Commun 148(1): 314-319
38. Symons JD, McMillin SL, Riehle C, Tanner J, Palionyte M, Hillas E, Jones D, Cooksey RC, Birnbaum MJ, McClain DA, Zhang QJ, Gale D, Wilson LJ, Abel ED (2009) Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure. Circ Res 104(9): 1085-1094
39. Pannirselvam M, Simon V, Verma S, Anderson T, Triggle CR (2003) Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice. Br J Pharmacol 140(4): 701-706
40. Minamiyama Y, Bito Y, Takemura S, Takahashi Y, Kodai S, Mizuguchi S, Nishikawa Y, Suehiro S, Okada S (2007) Calorie restriction improves cardiovascular risk factors via reduction of mitochondrial reactive oxygen species in type II diabetic rats. J Pharmacol Exp Ther 320(2):535-543
41. Ugochukwu NH, Figgers CL (2007) Attenuation of plasma dyslipidemia and oxidative damage by dietary caloric restriction in streptozotocin-induced diabetic rats. Chem Biol Interact 169(1): 32-41
42. Ungvari Z, Parrado-Fernandez C, Csiszar A, de Cabo R (2008) Mechanisms underlying caloric restriction and lifespan regulation: implications for vascular aging. Circ Res 102(5):519-528
43. Hoey BM, Butler J, Halliwell B (1988) On the specifi city of allopurinol and oxypurinol as inhibitors of xanthine oxidase. A pulse radiolysis determination of rate constants for reaction of allopurinol and oxypurinol with hydroxyl radicals. Free Radic Res Commun 4(4):259-263
44. Mizia-Stec K, Gasior Z, Zahorska-Markiewicz B, Holecki M, Haberka M, Mizia M, Gomulka S, Zak-Golab A, Goscinska A (2008) The indexes of arterial structure and function in women with simple obesity: a preliminary study Heart Vessels 23(4): 224-229
45. Fujii N, Tsuchihashi K, Sasao H, Eguchi M, Miurakami H, Hase M, Higashiura K, Yuda S, Hashimoto A, Miura T, Ura N, Shimamoto K (2008) Insulin resistance functionally limits endotheliumdependent coronary vasodilation in nondiabetic patients Heart Vessels 23(1):9-15